Cai, M., & Liu, T. (2026). From Algorithms to Assets: A Comprehensive Review of AI's Role in Preclinical Drug Discovery and the Hurdles to Clinical Translation. Pharmaceuticals (14248247), 19(5), 696. https://doi.org/10.3390/ph19050696
Chicago Style (17th ed.) CitationCai, Mengqi, and Tiancai Liu. "From Algorithms to Assets: A Comprehensive Review of AI's Role in Preclinical Drug Discovery and the Hurdles to Clinical Translation." Pharmaceuticals (14248247) 19, no. 5 (2026): 696. https://doi.org/10.3390/ph19050696.
MLA (9th ed.) CitationCai, Mengqi, and Tiancai Liu. "From Algorithms to Assets: A Comprehensive Review of AI's Role in Preclinical Drug Discovery and the Hurdles to Clinical Translation." Pharmaceuticals (14248247), vol. 19, no. 5, 2026, p. 696, https://doi.org/10.3390/ph19050696.